PHILADELPHIA, PA / ACCESS Newswire / March 12, 2025 / Kehoe Law Firm, P.C. continues its investigation on behalf of investors of bluebird bio (NASDAQ:BLUE) regarding the adequacy and fairness of the proposed acquisition of bluebird bio by "funds managed by global investment firms Carlyle (NASDAQ: CG) and SK Capital Partners, LP ("SK Capital") in collaboration with a team of highly experienced biotech executives."
On February 21, 2025, bluebird bio announced an agreement to be acquired in a deal bluebird bio said is a "transaction [that] is the only viable solution to generate value for stockholders."
bluebird bio investors interested in learning more about the investigation can complete Kehoe Law Firm's Stockholder Information Request form or send us a message to contact an attorney for a free, no-obligation legal evaluation.
For direct inquiries, bluebird bio investors should contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, or myarnoff@kehoelawfirm.com, info@kehoelawfirm.com.
If necessary, bluebird bio shareholders should copy/paste either https://kehoelawfirm.com/stockholder-information-request/ or https://kehoelawfirm.com/contact/ into their web browser.
ABOUT KEHOE LAW FIRM, P.C.
Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors. We litigate securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.
This press release may constitute attorney advertising.
SOURCE: Kehoe Law Firm, P.C.
View the original
press release on ACCESS Newswire
